Research Topics
| Aldemar DegrootSummaryAffiliation: Eli Lilly and Company Country: USA Publications
| Collaborators |
Detail Information
Publications
Dorsal and ventral hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe testsAldemar Degroot
Department of Psychology, University of Alberta, Edmonton, Alberta, Canada T6G 2E9
Brain Res 949:60-70. 2002..Overall, the results suggest that cholinergic stimulation in the dorsal and ventral hippocampus modulate anxiety, but that only the ventral hippocampal cholinergic system is involved in the passive avoidance of painful stimuli...
Anxiety is functionally segregated within the septo-hippocampal systemAldemar Degroot
Department of Psychology, University of Alberta, Edmonton, Alberta, Canada T6G 2E9
Brain Res 1001:60-71. 2004..Collectively, the data suggest that the control of specific anxiety reactions is functionally segregated within different aspects of the septo-hippocampal system...
Glucose increases hippocampal extracellular acetylcholine levels upon activation of septal GABA receptorsAldemar Degroot
Department of Psychology, University of Alberta, AB, Edmonton, Canada
Brain Res 979:71-7. 2003..Thus, glucose increases hippocampal extracellular ACh levels when the ACh system is inhibited, an effect that likely contributes to the effects of glucose on memory...
Genetic deletion of muscarinic M4 receptors is anxiolytic in the shock-probe burying modelAldemar Degroot
Eli Lilly and Company, Lilly Corporate Center, Neuroscience Discovery Research, Indianapolis, IN, 46285 0510, USA
Eur J Pharmacol 531:183-6. 2006..Therefore, muscarinic M4 receptors are of particular significance in anxiety modulation that seems dissociated from changes in long-term memory...
Fluoxetine disrupts the integration of anxiety and aversive memoriesAldemar Degroot
Eli Lilly and Company, Lilly Corporate Center, Neuroscience Discovery Research, Indianapolis, IN 46285-0510, USA
Neuropsychopharmacology 30:391-400. 2005..This reduces the emotional impact of aversive memories, thereby opposing consequent anxiety...
Genetic deletion and pharmacological blockade of CB1 receptors modulates anxiety in the shock-probe burying testAldemar Degroot
Eli Lilly and Company, Lilly Corporate Center, Neuroscience Discovery Research, Indianapolis, IN, 46285 0510, USA
Eur J Neurosci 20:1059-64. 2004..Collectively, these results suggest that CB1 receptor blockade reduces some, but not all, aspects of anxiety. The decrease in probe contacts induced by CB1 receptor blockade may be due to enhanced cognition...
Acute exposure to a novel object during consolidation enhances cognitionAldemar Degroot
Eli Lilly and Company, Lilly Corporate Center, Neuroscience Discovery Research, Indianapolis, IN 46285-0510, USA
Neuroreport 16:63-7. 2005..The data suggest that environmental enrichment during a critical period (consolidation) is sufficient to improve learning and memory. This effect is likely mediated through an enhancement of hippocampal cholinergic neurotransmission...
Genetic deletion of CB1 receptors improves non-associative learningAldemar Degroot
Eli Lilly and Company, Lilly Corporate Center, Neuroscience Discovery Research, Indianapolis, IN 46285 0510, USA
Behav Brain Res 162:161-4. 2005..We conclude that CB1 receptor gene invalidation improves habituation tentatively through an increase in cholinergic neurotransmission...
Exposure to an elevated platform increases plasma corticosterone and hippocampal acetylcholine in the rat: reversal by chlordiazepoxideAldemar Degroot
Neuroscience Discovery Research, Eli Lilly and Company, Lilly Corporate Center-DC0510, Indianapolis, IN, 46285-0510, USA
Eur J Pharmacol 493:103-9. 2004..These results provide direct evidence for the importance of the hippocampal cholinergic system in stress and provide validation for the elevated platform as a model of stress...
CB1 receptor antagonism increases hippocampal acetylcholine release: site and mechanism of actionAldemar Degroot
Eli Lilly and Company, Lilly Corporate Center, Neuroscience Discovery Research, Indianapolis, IN, USA
Mol Pharmacol 70:1236-45. 2006....
